Acquired CYP19A1 amplification is an early specific mechanism of aromatase inhibitor resistance in ERα metastatic breast cancer
- Submitting institution
-
Imperial College of Science, Technology and Medicine
- Unit of assessment
- 1 - Clinical Medicine
- Output identifier
- 3399
- Type
- D - Journal article
- DOI
-
10.1038/ng.3773
- Title of journal
- Nature Genetics
- Article number
- -
- First page
- 444
- Volume
- 49
- Issue
- 3
- ISSN
- 1546-1718
- Open access status
- Compliant
- Month of publication
- January
- Year of publication
- 2017
- URL
-
-
- Supplementary information
-
-
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- No
- Number of additional authors
-
18
- Research group(s)
-
A - Cancer
- Citation count
- 34
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
- -
- Author contribution statement
- -
- Non-English
- No
- English abstract
- -
